Christopher Goetz to Antipsychotic Agents
This is a "connection" page, showing publications Christopher Goetz has written about Antipsychotic Agents.
Connection Strength
1.190
-
An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother. 2011 Sep; 12(13):2009-24.
Score: 0.369
-
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening. Mov Disord. 2008 Aug 15; 23(11):1541-5.
Score: 0.304
-
Therapies for movement disorders. Arch Neurol. 2002 May; 59(5):699-702.
Score: 0.197
-
Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81.
Score: 0.087
-
Hallucinations in Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):331-42.
Score: 0.080
-
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2078-81.
Score: 0.068
-
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects. Mov Disord. 2006 Feb; 21(2):248-52.
Score: 0.064
-
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010 Aug; 67(8):996-1001.
Score: 0.022